In detail, 33 analyses, which involved in Brain and CNS cancer, Breast cancer, Lymphoma, Myeloma and many other kinds of cancers, showed statistically significant higher NEO1 mRNA expression levels in tumors, while 27 analyses, such as in Bladder cancer, Colorectal cancer and Kidney cancer, showed lower expression. Here, NEO1 is linked to urinary bladder cancer.